Post-Award Public Notice

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Notice type
Award Notice
Solicitation #
75F40126P00227
NAICS
334516
PSC
6640
Set-aside
No Set aside used
Posted
August 21, 2026
Response due
Place of performance
17776, MD

What this opportunity is

The U.S. Department of Health and Human Services, through the FDA, awarded a sole source, firm-fixed-price purchase order to Z-Spec, Inc. for specific analytical laboratory instruments, including the Z-max Analyzer and E-max PLUS Analyzer, along with necessary accessories. This opportunity does not have a set-aside for small businesses, meaning it is open to all business types, but is specifically suited for those capable of providing brand-name commercial products. As this is an award notice, interested parties should track similar opportunities rather than bid on this particular contract.

Analysis by Mindy, grounded in the SAM.gov notice.

Description

Post-Award Public Notice Posted Pursuant to 41 U.S.C. § 2304(f)(5) and RFO FAR Subpart 6.3 / FAR 6.305 Notice Type: Award Notice — Justification for Other Than Full and Open Competition Date Posted: 08/21/2026 Contract Award Date: 08/21/2026 SECTION 1 — CONTRACT INFORMATION Field Information Agency U.S. Department of Health and Human Services (HHS) Contracting Activity U.S. Food and Drug Administration (FDA), OƯice of Acquisitions and Grants Services (OAGS) Contract Number 75F40126P00227 Contract Type Firm-Fixed-Price (FFP) Purchase Order Contractor Name Z-Spec, Inc. Contractor Address 15 Tech Valley Drive, Suite 110 East Greenbush, NY 12061 Contractor UEI SAM T3BAMJU1A835 Total Contract Value $ 123,075.00 Period of Performance 09/14/2026-09/13/2027 Place of Performance / Delivery U.S. Food and Drug Administration, College Park, MD PSC Code 6640 — Laboratory Equipment and Supplies NAICS Code 334516 — Analytical Laboratory Instrument Manufacturing Small Business Size Standard 1,000 Employees -- 1 of 5 -- Field Information Acquisition Procedure FAR Part 12 — Commercial Products and Commercial Services (RFO) SECTION 2 — STATUTORY AUTHORITY FOR OTHER THAN FULL AND OPEN COMPETITION This contract was awarded without full and open competition pursuant to the authority of:  41 U.S.C. § 3304(a)(1) — Only one responsible source and no other supplies or services will satisfy agency requirements  RFO FAR 6.103-1 (formerly FAR 6.302-1) — Only one responsible source SECTION 3 — DESCRIPTION OF SUPPLIES ACQUIRED The FDA awarded a sole source, firm-fixed-price purchase order to Z-Spec, Inc. for the acquisition of the following brand-name commercial instruments: - Z-Spec, Inc. Part number (106-01) Z-max Analyzer - Z-Spec, Inc. Part number (102-02) E-max PLUS Analyzer - Accessories, including sample cups, sample prep kit, transporting case, food/plant standards kit. The instruments meet the following technical requirements: 1) System:  Detection Method: energy dispersive XRF  Optics: Doubly Curved Crystal (DCC) optics  Excitation: 17 keV excitation beam or greater  Power: compatible with standard U.S. 120V 60 Hz power  Portability:  Field-portable design (<10 kg) combined with high analytical sensitivity, enabling both laboratory and on-site testing -- 2 of 5 -- 2) Sample Preparation  Samples will be provided as dried powders, and purchase should include sample holders and/cup, along with XRF transparent film to hold powdered sample. 3) Performance Specifications - Required Limits of Detection  Must meet ultra-low limits of detection for toxic elements (e.g., As, Cd, Hg, Pb, Tl) required for FDA regulatory and research applications. Element LOD required (ug/g) As 0.03 Cd 0.04 Hg 0.06 Pb 0.06 Tl 0.06 4) Software and Data Management  Fundamental Parameters data model  Data Output: Integrated hardware/software architecture designed specifically for food safety and contaminant analysis workflows and data should be available for export in standard .txt or .csv formats  Connectivity: Ethernet, USB ports The OƯice of Chemistry and Toxicology, Division of Bioanalytical Chemistry, Chemical Contaminants Branch requires the purchase of two portable Mono-Chromatic High Definition X-ray fluorescence spectrometers (mHD-XRF systems): the Z-max Analyzer and the E-max PLUS Analyzer. In support of the FDA's public health mission, these systems will support rapid analytical testing of foods, dietary supplements, cosmetics, and spices for toxic elements including arsenic (As), cadmium (Cd), mercury (Hg) and lead (Pb) detection. The analytical capabilities may be extended to include additional elements as needed. SECTION 4 — RATIONALE FOR OTHER THAN FULL AND OPEN COMPETITION A. Unique and Proprietary Technology The Z-max and E-max PLUS Analyzers are proprietary instruments exclusively designed, developed, and manufactured by Z-Spec, Inc. These instruments employ patented optical and detection architectures that are unique to Z-Spec, Inc. and are protected by -- 3 of 5 -- intellectual property rights. These technologies are not available from any other manufacturer or source. B. No Technically Equivalent Substitute Market research conducted by the FDA prior to award confirmed that no other commercially available XRF or elemental analysis instrument provides equivalent analytical sensitivity, detection limits, and measurement methodology required to meet the Government's specific technical requirements. Conventional energy-dispersive XRF (EDXRF) instruments available from other manufacturers do not achieve the required detection performance levels. C. Only One Responsible Source Z-Spec, Inc. is the only responsible source capable of providing the Z-max and E-max PLUS Analyzers. No other vendor manufactures or supplies instruments of equivalent capability that would satisfy the Government's minimum needs in terms of the technical requirements. SECTION 5 — EFFORTS TO OBTAIN COMPETITION In accordance with RFO FAR 6.103-1 and prior to award, the FDA posted a Notice Of Intent For A Sole Source Award on SAM.gov on 07/29/2026, providing all interested parties 15 calendar days to respond with capability statements or oƯers demonstrating the ability to meet the Government's requirements.  No responses were received demonstrating the capability to meet the Government's requirements. Accordingly, the FDA determined that Z-Spec, Inc. is the only responsible source capable of satisfying the Government's requirements and proceeded with a sole source award. SECTION 6 — PRICE REASONABLENESS The Contracting OƯicer determined that the price of $ 123,075.00 is fair and reasonable based on comparison with the invoices provided by Z-Spec, Inc. of the same instruments sold to other commercial entities. SECTION 7 — MARKET RESEARCH -- 4 of 5 -- Market research was conducted by the FDA in accordance with RFO FAR Part 10. The market research confirmed that no other commercially available instrument meets the Govern

Source: SAM.gov, as posted. Verify the current solicitation before responding.

Pursue this opportunity with Mindy

See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.

View the original notice on SAM.gov ↗

Similar Active Opportunities (NAICS 334516)